You are here: Home » Markets » News
Business Standard

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

All that happened in today's trade

SI Reporter  |  New Delhi 

The Benchmark indices settled flat on Thursday after hitting new highs in Wednesday's trade as some company results including from Tech Mahindra, and JSW Energy disappointed investors, but gains in pharmaceutical shares lent some support. The markets had hit record highs in the previous session, on continued optimism after the government’s recent decision to inject more funds into state-run lenders. Overseas, European stocks were trading flat as investors waited for the latest rate decision from the Bank of England (BOE). Asian shares advanced after ...

MONTHLY STAR

Business Standard Digital

Business Standard Digital Monthly Subscription
149.00  
subscribe
Complete access to the premium product
Convenient - Pay as you go
Pay using Master/Visa Credit Card & ICICI VISA Debit Card
Auto renewed (subject to your card issuer's permission)
Cancel any time in the future
Requires personal information

What you get?

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all the content on any device through browser or app.
  • Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.
  • 18 years of archival data.

NOTE :

  • The product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the email with the cancellation request to assist@bsmail.in. Include your contact number for speedy action. Requests mailed to any other ID will not be acknowledged or actioned upon.

SMART MONTHLY

Business Standard Digital

Business Standard Digital - 12 Months
1499.00
subscribe
Get 12 months of Business Standard digital access
Single Seamless Sign-up to Business Standard Digital
Convenient - Once a year payment
Pay using an instrument of your choice - Credit/Debit Cards, Net Banking, Payment Wallets accepted
Exclusive Invite to select Business Standard events

What you get

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all content on any device through browser or app.
  • Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.

NOTE :

  • This product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.
Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

Vinod Nair, Head of Research, Geojit Financial Services    Market went through some profit-booking after touching the all time high. But the gradual change in FII inflows from negative to positive led by domestic cues will keep the India growth story intact. Pharma stocks emerged as a dark horse due to attractive valuations and expectation of faster USFDA approvals for plants. On the global front, Fed kept the rate on hold as expected, while rising optimism on economic development is adding more weights to a hike in the month of December which has largely been factored in the domestic market.

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

Market wrap-up by Nikhil Kamath, Co-Founder and Head of Trading, Zerodha   Markets closed the session flat for the day; pharma stocks were the best performers for the session, Divi's Labs was the best performer, notching up gains of 17% for the session. Sun Pharma, Lupin, and Aurobindo Pharma were the best performers at the index level. Markets corrected slightly at the opening and then continued to trade rangebound in a very small range throughout the session.    Domestic institutions continue to remain flush with liquidity whereas FIIs continue selling. Overall, we are yet to see the level of bullishness and complacency which could signal the end of the inherent bull trend. This rally could have further legs in the short term; we would still not advocate taking fresh longs at this juncture.

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

Sensex heatmap at close Source: BSE

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

Market breadth  The market breadth, indicating the overall health of the market, turned negative from positive. On BSE, 1,420 shares fell and 1,337 shares rose. A total of 142 shares were unchanged.

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

Broader markets underperform  The BSE Midcap and the BSE Smallcap indices settled 0.4% lower each. 

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

Markets at close The S&P BSE Sensex ended at 33,573, down 27 points, while the broader Nifty50 was ruling at 10,423, down 16 points. 

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

Sectoral trend Source: NSE

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

Bitcoin crosses $7000   Bitcoin reached yet another all-time high, surpassing  $7,000 for the first time ever, boosted by bets the cryptocurrency could enter the financial mainstream after the world's largest derivatives exchange operator said on Tuesday it would launch bitcoin futures.

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

JSW Steel: Firm profit outlook will help sustain sentiment   JSW Steel may have seen a relatively soft September quarter but its prospects remain firm in light of the improving demand environment, as well as profitability and firm prices. READ FULL ANALYSIS

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

HDFC Life IPO: From anchor investment to market share, all you need to know HDFC Standard Life Insurance, one of the top three private life insurers in profitability, will open its Rs 8,700-crore initial public offering (IPO) next Tuesday and close it on Thursday. This will be the fourth IPO of an HDFC arm.   "The issue has been attractively priced for retail investors. I would say investors should not look for the first day pop and invest in the company with a long-term horizon for good returns,” said HDFC Life MD & CEO Amitabh Chaudhry in the company’s IPO roadshow in New Delhi on Wednesday. HDFC Life will get listed on stock exchanges on November 17.    KEY THINGS TO KNOW ABOUT THE COMPANY'S IPO

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

SPML Infra zooms 20%   SPML Infra was locked in upper circuit of 20% at Rs 161 on the BSE after the company announced the successful implementation of Scheme for Sustainable Structuring of Stressed Assets (S4A). READ MORE

First Published: Thu, November 02 2017. 15:34 IST
RECOMMENDED FOR YOU

Sensex ends marginally lower, Nifty holds above 10,400; Nifty Pharma up 3%

All that happened in today's trade

The Benchmark indices settled flat on Thursday after hitting new highs in Wednesday's trade as some company results including from Tech Mahindra, and JSW Energy disappointed investors, but gains in pharmaceutical shares lent some support. The markets had hit record highs in the previous session, on continued optimism after the government’s recent decision to inject more funds into state-run lenders. Overseas, European stocks were trading flat as investors waited for the latest rate decision from the Bank of England (BOE). Asian shares advanced after ...

image
Business Standard
177 22